Acebutolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Acebutolol.
Acetyldigitoxin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Acetyldigitoxin.
Aclarubicin
Amphotericin B may increase the nephrotoxic activities of Aclarubicin.
Advertisement
Alclometasone
Alclometasone may increase the hypokalemic activities of Amphotericin B.
Aldesleukin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Aldesleukin.
Aldosterone
Aldosterone may increase the hypokalemic activities of Amphotericin B.
Advertisement
Aliskiren
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Aliskiren.
Amcinonide
Amcinonide may increase the hypokalemic activities of Amphotericin B.
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Amphotericin B.
Advertisement
Amifostine Anhydrous
The risk or severity of adverse effects can be increased when Amifostine is combined with Amphotericin B.
Amikacin
Amphotericin B may increase the nephrotoxic activities of Amikacin.
Amiloride
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Amiloride.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Amphotericin B.
Amlodipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Amlodipine.
Amobarbital
Amobarbital may increase the hypotensive activities of Amphotericin B.
Amorolfine
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Amorolfine.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Amyl Nitrite.
Androstenedione
Androstenedione may increase the hypokalemic activities of Amphotericin B.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Amphotericin B.
Anidulafungin
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Anidulafungin.
Apomorphine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Apomorphine.
Apraclonidine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Apraclonidine.
Arbekacin
Amphotericin B may increase the nephrotoxic activities of Arbekacin.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Amphotericin B.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Arsenic trioxide.
Artemether
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Artemether.
Atenolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Atenolol.
Atorvastatin
The risk or severity of rhabdomyolysis can be increased when Amphotericin B is combined with Atorvastatin.
Azilsartan
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Azilsartan medoxomil.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Amphotericin B.
Barbital
Barbital may increase the hypotensive activities of Amphotericin B.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Amphotericin B.
Beclomethasone Dipropionate
Beclomethasone dipropionate may increase the hypokalemic activities of Amphotericin B.
Benazepril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Benazepril.
Bencyclane
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Bencyclane.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bendroflumethiazide.
Benzoic Acid
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Benzoic Acid.
Bepridil
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bepridil.
Betamethasone
Betamethasone may increase the hypokalemic activities of Amphotericin B.
Betaxolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Betaxolol.
Bifonazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Bifonazole.
Bisoprolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bisoprolol.
Bortezomib
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bortezomib.
Bretylium
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bretylium.
Brimonidine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Brimonidine.
Bromocriptine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bromocriptine.
Budesonide
Budesonide may increase the hypokalemic activities of Amphotericin B.
Bumetanide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bupivacaine.
Buspirone
The metabolism of Buspirone can be decreased when combined with Amphotericin B.
Busulfan
The serum concentration of Busulfan can be increased when it is combined with Amphotericin B.
Butenafine
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Butenafine.
Butoconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Butoconazole.
Canagliflozin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Canagliflozin.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Candesartan cilexetil.
Captopril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Captopril.
Carteolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Carteolol.
Carvedilol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Carvedilol.
Caspofungin
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Caspofungin.
Cerivastatin
The risk or severity of rhabdomyolysis can be increased when Amphotericin B is combined with Cerivastatin.
Chlorothiazide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Chlorothiazide.
Chloroxine
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Chloroxine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Chlorpromazine.
Chlorthalidone
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Chlorthalidone.
Ciclesonide
Ciclesonide may increase the hypokalemic activities of Amphotericin B.
Ciclopirox
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Ciclopirox.
Cilazapril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Cilazapril.
Cinnarizine
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Cinnarizine.
Cisapride
The serum concentration of Cisapride can be increased when it is combined with Amphotericin B.
Clevidipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Clevidipine.
Clobetasol
Clobetasol may increase the hypokalemic activities of Amphotericin B.
Clobetasol Propionate
Clobetasol propionate may increase the hypokalemic activities of Amphotericin B.
Clobetasone
Clobetasone may increase the hypokalemic activities of Amphotericin B.
Clocortolone
Clocortolone may increase the hypokalemic activities of Amphotericin B.
Clofarabine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Clofarabine.
Clomipramine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Clomipramine.
Clonidine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Clonidine.
Clotrimazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Clozapine.
Colistimethate
Amphotericin B may increase the nephrotoxic activities of Colistimethate.
Conivaptan
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Conivaptan.
Cordycepin
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Cordycepin.
Cortisone Acetate
Cortisone acetate may increase the hypokalemic activities of Amphotericin B.
Cyclandelate
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Cyclandelate.
Cyclosporine
Amphotericin B may increase the nephrotoxic activities of Cyclosporine.
Dapagliflozin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dapagliflozin.
Daunorubicin
Amphotericin B may increase the nephrotoxic activities of Daunorubicin.
Decanoic Acid
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Capric acid.
Deflazacort
Deflazacort may increase the hypokalemic activities of Amphotericin B.
Desflurane
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Desflurane.
Deslanoside
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Deslanoside.
Desonide
Desonide may increase the hypokalemic activities of Amphotericin B.
Desoximetasone
Desoximetasone may increase the hypokalemic activities of Amphotericin B.
Desoxycorticosterone acetate
Desoxycorticosterone acetate may increase the hypokalemic activities of Amphotericin B.
Desoxycorticosterone Pivalate
Desoxycorticosterone Pivalate may increase the hypokalemic activities of Amphotericin B.
Dexamethasone
Dexamethasone may increase the hypokalemic activities of Amphotericin B.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dexmedetomidine.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Diclofenamide.
Didanosine
Didanosine can cause a decrease in the absorption of Amphotericin B resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diflorasone
Diflorasone may increase the hypokalemic activities of Amphotericin B.
Diflucortolone
Difluocortolone may increase the hypokalemic activities of Amphotericin B.
Difluprednate
Difluprednate may increase the hypokalemic activities of Amphotericin B.
Digitoxin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Digitoxin.
Digoxin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Digoxin.
Dihydrostreptomycin
Amphotericin B may increase the nephrotoxic activities of Dihydrostreptomycin.
Diltiazem
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dinutuximab.
Dipyridamole
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dipyridamole.
Docetaxel
The metabolism of Docetaxel can be decreased when combined with Amphotericin B.
DOCETAXEL ANHYDROUS
The metabolism of Docetaxel can be decreased when combined with Amphotericin B.
Dofetilide
The serum concentration of Dofetilide can be increased when it is combined with Amphotericin B.
Doxazosin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Doxazosin.
Doxorubicin
Amphotericin B may increase the nephrotoxic activities of Doxorubicin.
Doxorubicin Hydrochloride
Amphotericin B may increase the nephrotoxic activities of Doxorubicin.
Duloxetine
Amphotericin B may increase the orthostatic hypotensive activities of Duloxetine.
Econazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Econazole.
Econazole Nitrate
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Econazole.
Efinaconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Efinaconazole.
Empagliflozin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Empagliflozin.
Enalapril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Enalaprilat.
Epirubicin
Amphotericin B may increase the nephrotoxic activities of Epirubicin.
Eplerenone
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Eplerenone.
Epoprostenol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Epoprostenol.
Eprosartan
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Eprosartan.
Esmolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Esmolol.
Estrone
Estrone may increase the hypokalemic activities of Amphotericin B.
Ethacrynate
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Etacrynic acid.
Ethosuximide
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Ethosuximide.
Etravirine
The serum concentration of Etravirine can be increased when it is combined with Amphotericin B.
Felodipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Felodipine.
Fendiline
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Fendiline.
Fenoldopam
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Fenoldopam.
Fluconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Fluconazole.
Flucytosine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Flucytosine.
Fludrocortisone
Fludrocortisone may increase the hypokalemic activities of Amphotericin B.
Flumethasone
Flumethasone may increase the hypokalemic activities of Amphotericin B.
Flunarizine
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Flunarizine.
Flunisolide
Flunisolide may increase the hypokalemic activities of Amphotericin B.
Flunisolide Anhydrous (obsolete)
Flunisolide may increase the hypokalemic activities of Amphotericin B.
Fluocinolone Acetonide
Fluocinolone Acetonide may increase the hypokalemic activities of Amphotericin B.
Fluocinonide
Fluocinonide may increase the hypokalemic activities of Amphotericin B.
Fluocortolone
Fluocortolone may increase the hypokalemic activities of Amphotericin B.
Fluorometholone
Fluorometholone may increase the hypokalemic activities of Amphotericin B.
FLUPREDNIDENE
Fluprednidene may increase the hypokalemic activities of Amphotericin B.
Fluprednisolone
Fluprednisolone may increase the hypokalemic activities of Amphotericin B.
Flurandrenolide
Flurandrenolide may increase the hypokalemic activities of Amphotericin B.
Fluspirilene
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Fluspirilene.
Fluticasone Furoate
Fluticasone furoate may increase the hypokalemic activities of Amphotericin B.
Fluticasone propionate
Fluticasone propionate may increase the hypokalemic activities of Amphotericin B.
Fluvastatin
The risk or severity of rhabdomyolysis can be increased when Amphotericin B is combined with Fluvastatin.
Formestane
Formestane may increase the hypokalemic activities of Amphotericin B.
Foscarnet
Foscarnet may increase the nephrotoxic activities of Amphotericin B.
Fosinopril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Fosinopril.
Fosphenytoin
The serum concentration of Amphotericin B can be decreased when it is combined with Fosphenytoin.
Framycetin
Amphotericin B may increase the nephrotoxic activities of Framycetin.
Furosemide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Furosemide.
Gabapentin
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Gabapentin.
Gallopamil
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Gallopamil.
Gentamicin
Amphotericin B may increase the nephrotoxic activities of Gentamicin.
Glyphosate
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Glyphosate.
Griseofulvin
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Griseofulvin.
Griseofulvin microsize
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Griseofulvin.
Guanfacine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Guanfacine.
Halcinonide
Halcinonide may increase the hypokalemic activities of Amphotericin B.
Halobetasol
Ulobetasol may increase the hypokalemic activities of Amphotericin B.
Haloprogin
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Haloprogin.
Halothane
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Halothane.
Hexetidine
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Hexetidine.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Amphotericin B.
Hydralazine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Hydralazine.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Hydrochlorothiazide.
Hydrocortisone
Hydrocortisone may increase the hypokalemic activities of Amphotericin B.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Hydroflumethiazide.
Idarubicin
Amphotericin B may increase the nephrotoxic activities of Idarubicin.
Iloprost
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Iloprost.
Imidapril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Imipramine.
Inamrinone
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Amrinone.
Indapamide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Indapamide.
Indoramin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Indoramin.
Irbesartan
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Irbesartan.
Isocarboxazid
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isocarboxazid.
Isoconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Isoconazole.
Isoflurane
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isoflurane.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isoxsuprine.
Isradipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isradipine.
Itraconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Itraconazole.
Kanamycin
Amphotericin B may increase the nephrotoxic activities of Kanamycin.
kanamycin A
Amphotericin B may increase the nephrotoxic activities of Kanamycin.
Ketoconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Ketoconazole.
Labetalol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Labetalol.
Lacidipine
Amphotericin B may increase the hypotensive activities of Lacidipine.
Lamotrigine
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Lamotrigine.
Lercanidipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Lercanidipine.
Levetiracetam
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Levetiracetam.
Levobunolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Levobupivacaine.
Levodopa
Amphotericin B may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Levosimendan.
Lisinopril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Lisinopril.
Lofexidine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Lofexidine.
Loperamide
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Loperamide.
Losartan
The metabolism of Losartan can be decreased when combined with Amphotericin B.
Loteprednol
Loteprednol may increase the hypokalemic activities of Amphotericin B.
Lovastatin
The risk or severity of rhabdomyolysis can be increased when Amphotericin B is combined with Lovastatin.
Magnesium Sulfate
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Magnesium sulfate.
Manidipine
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Mannitol.
Mecamylamine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Mecamylamine.
Medrysone
Medrysone may increase the hypokalemic activities of Amphotericin B.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Amphotericin B.
Mepirodipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Barnidipine.
Methazolamide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Amphotericin B.
Methsuximide
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Methsuximide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Methyclothiazide.
Methyldopa
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Methyldopa.
METHYLDOPA ANHYDROUS
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Methyldopa.
Methylprednisolone
Methylprednisolone may increase the hypokalemic activities of Amphotericin B.
Metipranolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Metipranolol.
Metolazone
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Metolazone.
Metoprolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Metoprolol.
Metrizamide
Amphotericin B may increase the nephrotoxic activities of Metrizamide.
Mibefradil
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Mibefradil.
Micafungin
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Micafungin.
Miconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Miconazole.
Miltefosine
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Miltefosine.
Minoxidil
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Minoxidil.
Moexipril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Moexipril.
Mometasone
Mometasone may increase the hypokalemic activities of Amphotericin B.
Morphine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Morphine.
Moxonidine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Moxonidine.
Nabilone
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nabilone.
Nadolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nadolol.
Naftifine
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Naftifine.
Natamycin
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Natamycin.
Nebivolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nebivolol.
Neomycin
Amphotericin B may increase the nephrotoxic activities of Neomycin.
Nesiritide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nesiritide.
Netilmicin
Amphotericin B may increase the nephrotoxic activities of Netilmicin.
Nicardipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nicardipine.
Nicorandil
Nicorandil may increase the hypotensive activities of Amphotericin B.
Nifedipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nifedipine.
Nilvadipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nilvadipine.
Nimesulide
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Nimesulide.
Nimodipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nimodipine.
Nisoldipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nisoldipine.
Nitrendipine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nitric Oxide.
Nitroglycerin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nitroglycerin.
Nitroprusside
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nitroprusside.
Nitroxoline
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Nitroxoline.
Nystatin
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Nystatin.
Obinutuzumab
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Obinutuzumab.
Octylonium
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Otilonium.
Olmesartan
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Olmesartan.
Ouabain
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Ouabain.
Ovine Digoxin Immune Fab
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Digoxin Immune Fab (Ovine).
Oxiconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Oxiconazole.
Oxprenolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Oxprenolol.
Paclitaxel
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Paclitaxel.
Pafuramidine
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Pafuramidine.
Papaverine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Papaverine.
Paramethasone
Paramethasone may increase the hypokalemic activities of Amphotericin B.
Paregoric
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Morphine.
Paromomycin
Amphotericin B may increase the nephrotoxic activities of Paromomycin.
Penbutolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Penbutolol.
Pentamidine
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Pentamidine.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Amphotericin B.
Perindopril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Perindopril.
Phenelzine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Phenelzine.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Amphotericin B.
Phenoxybenzamine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Phenoxybenzamine.
Phentolamine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Phentolamine.
Phentolamine Mesylate
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Phentolamine.
Phenytoin
The serum concentration of Phenytoin can be increased when it is combined with Amphotericin B.
Picosulfuric Acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Amphotericin B.
Pinaverium
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Pinaverium.
Pindolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Pipamperone.
Pirarubicin
Amphotericin B may increase the nephrotoxic activities of Pirarubicin.
Pitavastatin
The risk or severity of rhabdomyolysis can be increased when Amphotericin B is combined with Pitavastatin.
Plicamycin
Amphotericin B may increase the nephrotoxic activities of Plicamycin.
Posaconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Posaconazole.
Pramipexole
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Pramipexole.
Prasterone
Prasterone may increase the hypokalemic activities of Amphotericin B.
Pravastatin
The risk or severity of rhabdomyolysis can be increased when Amphotericin B is combined with Pravastatin.
Prazosin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Prazosin.
Prednicarbate
Prednicarbate may increase the hypokalemic activities of Amphotericin B.
Prednisolone
Prednisolone may increase the hypokalemic activities of Amphotericin B.
Prednisone
Prednisone may increase the hypokalemic activities of Amphotericin B.
Pregnenolone
Pregnenolone may increase the hypokalemic activities of Amphotericin B.
Prenylamine
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Prenylamine.
Primidone
Primidone may increase the hypotensive activities of Amphotericin B.
Progesterone
The absorption of Progesterone can be decreased when combined with Amphotericin B.
Propofol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Propofol.
Propranolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Propranolol.
Proscillaridin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Proscillaridin.
Quetiapine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Quetiapine.
Quinapril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Quinapril.
Quinidine
The serum concentration of Quinidine can be increased when it is combined with Amphotericin B.
Ramipril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Ramipril.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Amphotericin B.
Rasagiline
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Rasagiline.
Remifentanil
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Remifentanil.
Reserpine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Reserpine.
Rifabutin
The serum concentration of Rifabutin can be increased when it is combined with Amphotericin B.
Rifampin
The serum concentration of Rifampicin can be increased when it is combined with Amphotericin B.
Rifapentine
The serum concentration of Rifapentine can be increased when it is combined with Amphotericin B.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Amphotericin B.
Rimexolone
Rimexolone may increase the hypokalemic activities of Amphotericin B.
Riociguat
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Riociguat.
Risperidone
Amphotericin B may increase the hypotensive activities of Risperidone.
Ropinirole
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Ropivacaine.
Rosuvastatin
The risk or severity of rhabdomyolysis can be increased when Amphotericin B is combined with Rosuvastatin.
Rotigotine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Rotigotine.
Sacubitril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Sacubitril.
Salicylic Acid
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Salicylic acid.
Secobarbital
Secobarbital may increase the hypotensive activities of Amphotericin B.
Selegiline
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Selegiline.
Sertaconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Sertaconazole.
Sevoflurane
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Sevoflurane.
Simvastatin
The risk or severity of rhabdomyolysis can be increased when Amphotericin B is combined with Simvastatin.
Sirolimus
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Sirolimus.
Sisomicin
Amphotericin B may increase the nephrotoxic activities of Sisomicin.
Solifenacin
The metabolism of Solifenacin can be decreased when combined with Amphotericin B.
Sotalol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Sotalol.
Spectinomycin
Amphotericin B may increase the nephrotoxic activities of Spectinomycin.
Spironolactone
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Spironolactone.
Streptokinase
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Streptokinase.
Streptomycin
Amphotericin B may increase the nephrotoxic activities of Streptomycin.
Streptozocin
Amphotericin B may increase the nephrotoxic activities of Streptozocin.
Sucralfate
Sucralfate can cause a decrease in the absorption of Amphotericin B resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sufentanil
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Sufentanil.
Sulconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Sulconazole.
Sunitinib
The metabolism of Sunitinib can be decreased when combined with Amphotericin B.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Amphotericin B.
Tamsulosin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tamsulosin.
Tavaborole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Tavaborole.
Telmisartan
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Telmisartan.
Terazosin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Terazosin.
Terbinafine
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Terbinafine.
Terconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Terconazole.
Thalidomide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Thalidomide.
Thiamylal
Thiamylal may increase the hypotensive activities of Amphotericin B.
Thiopental
Thiopental may increase the hypotensive activities of Amphotericin B.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Amphotericin B.
Thioridazine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Thioridazine.
Thymol
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Thymol.
Timolol
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Timolol.
Timolol Anhydrous
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Timolol.
Tioconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Tioconazole.
Tixocortol
Tixocortol may increase the hypokalemic activities of Amphotericin B.
Tizanidine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tizanidine.
Tobramycin
Amphotericin B may increase the nephrotoxic activities of Tobramycin.
Tolazoline
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tolazoline.
Tolcapone
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tolcapone.
Tolfenamic Acid
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Tolfenamic Acid.
Tolnaftate
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Tolnaftate.
Torsemide
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Torasemide.
Trandolapril
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Trandolapril.
Tranilast
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Tranilast.
Tranylcypromine
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tranylcypromine.
Tretinoin
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tretinoin.
Triamcinolone
Triamcinolone may increase the hypokalemic activities of Amphotericin B.
Triamterene
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Triamterene.
Trimebutine
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Trimebutine.
Trimethadione
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Trimethadione.
Trimetrexate
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Trimetrexate.
Valrubicin
Amphotericin B may increase the nephrotoxic activities of Valrubicin.
Valsartan
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Valsartan.
Verapamil
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Verapamil.
Vinpocetine
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Vinpocetine.
Voriconazole
The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Voriconazole.
Ziconotide
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Ziconotide.
Zolpidem
The serum concentration of Zolpidem can be increased when it is combined with Amphotericin B.
Zonisamide
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Zonisamide.
